SynGen
Sacramento
About SynGen
SynGen enables regenerative cures through innovative engineering. The company invents and commercializes products that utilize single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue. Their products provide an important enabling platform for use in diagnostic, research, and clinical processes. Their inventions are based upon interdisciplinary fields that apply principles of engineering and life sciences to develop solutions required for regenerative medicine.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.8M
- Funding stage: M&A
- Last round: Series Unknown (Mar 2017)
- Website: syngeninc.com
- Phone: +119167060923
Industries & Categories
Biotechnology, Health Care, Industrial Engineering, Medical
Social Profiles
Canonical: https://fsome.com/organization/syngen-171690 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.